DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Hamid SS, Etzlon O, Lurie Y. et al.
Abstract 927: A phase 2 randomized clinical trial to evaluate the safety and efficacy of pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection. Interim results from the LIMT HDV study.
2017
Access:
We do not assume any responsibility for the contents of the web pages of other providers.